Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Cameroon has been increasing steadily over the past few years.
Customer preferences: Cameroon has a population of over 26 million people, and the majority of the population is under the age of 25. This young population has been a driving force behind the increasing demand for vaccines in the country. In addition, the government has been actively promoting vaccination programs in order to prevent the spread of diseases.
Trends in the market: The vaccines market in Cameroon has been growing steadily over the past few years. This growth can be attributed to the increasing demand for vaccines, as well as the government's efforts to promote vaccination programs. In addition, there has been an increase in the number of private healthcare providers in the country, which has led to increased access to vaccines for the population.
Local special circumstances: Cameroon is a lower-middle-income country, and as such, the cost of vaccines can be a barrier for some individuals. However, the government has been working to make vaccines more affordable and accessible to the population. In addition, there are some cultural beliefs in certain regions of the country that can discourage individuals from getting vaccinated. The government has been working to address these beliefs through education and awareness campaigns.
Underlying macroeconomic factors: The economy of Cameroon has been growing steadily over the past few years, which has led to an increase in disposable income for many individuals. This increase in disposable income has made it easier for individuals to afford vaccines. In addition, the government has been investing in the healthcare sector, which has led to an increase in the availability of vaccines in the country. Overall, the vaccines market in Cameroon is expected to continue to grow in the coming years, as the government continues to promote vaccination programs and the economy continues to grow.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
